Latest filing published 07 Jun 2018 for KYTO BIOPHARMA INC, €263k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Comindus Finance Corp. is a declared insider at 2 companies; the most frequent names are Kyto Biopharma Inc and Osprey Gold Corp. The record holds 8 filings, for trades running from 9 September 2010 to 25 April 2018.
Purchases make up the whole of the open-market record (1 purchase). The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
On 7 June 2018 came the latest disclosure, a transaction for €263k in Kyto Biopharma Inc. The most recent open-market purchase was published on 14 January 2014, 4,665 days ago. Filings reach the SEC (Form 4) feed a median of 28 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations